PREVENTION AND VACCINATION AGAINST HEPATITIS B VIRUS  INFECTION: A REVIEW

Mahbub-E- Sobhani; Tawhidur  Rahman

doi:10.53808/KUS.2000.2.1.167-182-Ls

Authors

Mahbub-E- Sobhani Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh
Tawhidur Rahman Biotechnology and Genetic Engineering Discipline, Khulna University, Khulna 9208, Bangladesh

DOI:

https://doi.org/10.53808/KUS.2000.2.1.167-182-Ls

Keywords:

Hepatitis B; Surface antigen; Infection; Vaccine; Prevention; Immunization

Abstract

Hepatitis B virus, one of the world’s most widely spread infectious viral agents, is a major cause of millions of disease and death each year. The existence of approximately 350 million carriers in the world provides a reservoir for continuous transmission of the virus. At present, there is no effective treatment for the diseases caused by hepatitis B virus, and hence prevention of the infection through vaccination plays a significant role in eradicating the diseases caused by the virus. The present review is based on the prevention and vaccination strategies against hepatitis B virus infection and the aim of the study is mainly directed to the development and safety of different hepatitis B vaccines that are already developed and/or on the way to development. The review is mainly based on secondary publications for the last ten years. The review helps in developing ideas about the prevention and vaccination strategies against hepatitis B virus and also the problems that have arisen during vaccination.

Downloads

Download data is not yet available.

References

Abbott Diagnostic Educational Services, 1994. Hepatitis Learning Guide. Abbot Laboratories, Abbot Park, Illinois, U.S.A, pp. 1-3, 47-49.

Andjaparidze, A.G., 1996. Universal precautions for hepatitis B virus infection. In: S.K. Sarin and A.K. Singal (eds.), Hepatitis B in India (Problems & Prevention). CBS Publishers & Distributors, New Delhi, pp. 83-87.

Arya, S.C., 1995. Astounding influencing of ‘substance abuse’, malnutrition and immune suppression on response to hepatitis B vaccine. Vaccine, 13(9): 879. [Letter]

Crawford, J.M., 1994. The liver and the billiary tract. In: R.S. Cotran, V. Kumar and S.L. Robbins (eds.), Robins Pathological Basis of Disease. Prism Book (pvt.) Ltd., Bangalore, India, pp. 844-846.

Davis, H.L., Millan, C.L.B., Mancini, M. and McCluskie, M. J., 1997. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice. Vaccine, 15(8): 845- 852.

Ellis, R. W., Kniskern, P. J. and Hagopian, A., 1988. Preparation and testing of a recombinant-derived hepatitis

B vaccine consisting of pre-S2 + S polypeptides. In: A.J. Zuckerman (ed), Viral hepatitis and liver disease. Alan R. Liss, New York, pp. 1079-1086.

Gill, H.H., 1996. Hepatis B vaccine: current and new. In: S.K. Sarin and A.K. Singal (eds.), Hepatitis B in India (Problems & Prevention). CBS Publishers & Distributors, New Delhi, pp. 115-122.

Gitlin, N., 1997. Hepatitis B: Diagnosis, prevention and treatment. Clin. Chem., 43: 1500-1506.

Grob, P.J, Hallauer, M., Kane, M., Meheus, M.A. and Damme, P.V. , 1998. Hepatitis B: a serious public health threat. Vaccine, 16: S1-S2.

Grotto, I., Mandel, Y., Ephros, M., Ashkenazi, I. and Shemer, J., 1998. Major adverse reactions to yeast derived hepatitis B vaccines- a review. Vaccine, 16(4): 329-334.

Hollinger, F.B., 1996. Hepatitis B virus. In: B. N. Fields, D.M. Knipe and P.M. Howley (eds.), Fields Virology, 3rd Edn., Volume Two. Lippincott-Raven, Philadelphia, New York, pp. 2739-2807.

Itoh, Y., Takai, E. and Ohnuma, H., 1986. A synthetic peptide vaccine involv ing the product of the pre-S2 region of hepatitis B virus DNA : DNA protective efficacy in chimpanzees. Proceeding of the National Academy of Science of the USA, 83: 9174-9178.

Jilg, W., 1998. Novel hepatitis B vaccines. Vaccine, 16: S65-S68.

Kane, M.A., 1998. Status of hepatitis B immunization in 1998. Vaccine, 16: S104-S108.

Kar, P., 1996. Post -exposure prophylaxis of hepatitis B virus (HBV) infection. In: S.K. Sarin and A.K. Singal (eds.), Hepatitis B in India (Problems & Prevention). CBS Publishers & Distributors, New Delhi, pp.184-189.

Kithen, A, 1998. Hepatitis B and blood safety. Vaccine, 16: S34-S37.

Koike, Y., Yoo, Y.C. and Mitobe, M., 1998. Enhancing activity of mycobacterial cell -derived adjutants on immunogenicity of recombinant human hepatitis B virus vaccine. Vaccine, 16(20): 1982-1989.

Mason, H.S., Lam, D.M.K. and Arntzen, C.J., 1992. Expression of hepatitis B surface antigen in transgenic plants. Proceeding of the National Academy of Science of the USA, 89: 11745-11749.

Mast, E.E., Mahoney., F,J., Alter, M.J. and Margolis, H.S., 1998. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine, 16: S48-S51.

Millich, D.R., Thornton, G.B. and Neurath, A.R., 1985. Enhanced immunogenicity of the pre-S region hepatitis B suface antigen. Science, 228: 1195-1199.

Miskovsky, E., Gershman, K. and Clements, M.L., 1991. Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S-antigens and pre-S2-S antigens. Vaccine, 9: 346-350.

Mustafa, M. , Islam, N. and Rahman, M., 1991. Prevalence of hepatitis B surface antigen in Dhaka, Bangladesh. Journal of Preventive and Social Medicine, 10 (1): 22-26.

Neurath, A.R., Kent, S.B. and Strick, N., 1985. Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus envelope gene. J. Med. Viro., 17: 119-125.

Papaevangelou, G., 1998. Current combined vaccines with hepatitis B. Vaccine, 16: S69-S72.

Papaevangelou, G., Bora, C. and Roumeliotoua, A., 1996. Immunogenicity of a combined hepatitis A/hepatitis B vaccine. IX Triennial symposium on Viral Hepatitis and Liver Disease, Abstract C322, 21-25 April 1996, Rome, Italy, 280 pp.

Papaevangelou, G., Karvelis, E. and Alexiou, D., 1995. E valuation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to health infants according to a three-dose vaccination schedule. Vaccine, 13: 175-178

Poovorawan, Y., Thambonlers, A. and Sanpaurt s, S., 1994. The immunogenicity and reactogenicity of combined tetravalent DTP and hepatitis B vaccine in infants. In: K. Nishioka, H. Suzuki, S. Mishito and T. Oda (eds.), Viral Hepatitis and Liver Disease. Springer -Verlag, Berlin, pp. 526-529.

Prince, A.M., 1997. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine, 15(8): 916-919.

Robinson, H.L., 1997. Nucleic acid vaccines: an overview. Vaccine, 15(8): 785-787

Safary, A., 1996. Hepatitis B Vaccination - Now and in the Future. In: S.K. Sarin and A.K. Singal (eds.), Hepatitis B in India (Problems & Prevention). CBS Publishers & Distributors, New Delhi, pp. 132-138.

Schodel, F., Milich, D.R. and Will, H., 1990. Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination. J. Immunol , 145: 4317-4321

Schreuder, M.P., Deen, C., Boersma, W.J.A. and Pouwels, P.H., 1996. Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine, 14(5): 383-388.

Shiraki, K. and Takahara, T., 1993. Recombinant Oka varicella vaccine as a live hepatitis B virus vaccine. Nippon-Rinsho, 51(1): 241-247.

Shiraki, K., Ochiai, H., Matsui, S., Aiba, N., Yoshida, Y., Okuno, T., Yamanishi, K. and Takahashi, M., 1992. Processing of hepatitis B surface antigen expressed by recombinant Oka varicella vaccine. J. Gen. Virol ., 73 (6): 1401-1407.

Tayal, S.C. and Sankar, K.N., 1994. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV infected individuals. AIDS, 8: 558-559.

Yao, G.B., 1996. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut, 38 (Suppl 2): S39-S42.

Yao, J.L., 1996. Perinatal transmission of hepatitis B vi rus infection and vaccination in China. Gut , 38 (Suppl 2): S37-S38.

Yap, L., Guan, R. and Chan, S.H., 1992. Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - a preliminary study on immunogenicity. Vaccine, 10: 439-442.

Zuckerman, A.J., Zuckerman. J.N. and Harrison, T.J., 1995. Prevention. In: A.J. Zuckerman and H.C. Thomas (eds.), Viral Hepatitis (Scientific Basis and Clinical Management). Churchill Livingstone, London, pp. 217-225.